异钩藤碱抑制PDGF-BB诱导肺动脉平滑肌细胞增殖的实验研究

doi:10.6040/j.issn.1671-7554.0.2014.575

摘要/Abstract

摘要： 目的探讨异钩藤碱对血小板源性生长因子BB(PDGF-BB)诱导的肺动脉平滑肌细胞(PASMCs)增殖的影响及其机制。方法建立PDGF-BB诱导的PASMCs增殖模型,通过MTT比色法和台盼蓝拒染法检测异钩藤碱对PASMCs增殖的影响及细胞毒性,流式细胞术检测细胞周期变化,Western blotting检测细胞周期相关蛋白的表达及血小板源性生长因子受体β(PDGF-Rβ)信号通路蛋白表达及磷酸化的影响。结果与正常对照相比,加入PDGF-BB(20 ng/mL)培养24 h,可促进PASMCs增殖约2.5倍;异钩藤碱剂量依赖性地抑制PDGF-BB诱导的PASMCs增殖;异钩藤碱(25 μmol/L)明显抑制PDGF-BB诱导的S期细胞比例升高;Western blotting结果显示,异钩藤碱可抑制PDGF-BB诱导的cyclin D1、CDK6的表达和p27^kip1的降解,下调PDGF-Rβ及其下游信号分子AKT、糖原合成激酶(GSK)3β的磷酸化。结论异钩藤碱通过将细胞周期阻滞于G₀/G₁期来抑制PDGF-BB诱导的PASMCs增殖,其机制可能为通过抑制PDGF-Rβ及其下游信号通路的磷酸化、进而调节细胞周期相关蛋白的合成和降解来实现。

关键词: 血小板源性生长因子, 糖原合成激酶3β, 肺动脉平滑肌细胞, 增殖, 异钩藤碱

Abstract: Objective To investigate the effect of isorhynchophylline on platelet-derived growth factor (PDGF)-BB-induced pulmonary artery smooth muscle cells (PASMCs) proliferation and the related mechanism. Methods In PDGF-BB-induced PASMCs proliferation model, the effect and cytotoxicity of isorhynchophylline on PDGF-BB-induced PASMCs proliferation were measured by MTT assay and trypan blue exclusion, and the cell cycle progression was measured by flowcytometry. The expression of cell cycle-related protein and PDGF receptor β (PDGF-Rβ) signaling pathway in PDGF-BB-stimulated PASMCs were measured by Western blotting. Results Compared with the controls, the number of PASMCs increased approximately 2.5 fold after cultured with 20 ng/mL PDGF-BB for 24 h. Isorhynchophylline inhibited PDGF-BB-induced PASMCs proliferation in a concentration-dependent manner. 25 μmol/L isorhynchophylline inhibited the increase of PDGF-BB-induced PASMCs S phase proportion. Western blotting results indicated that isorhynchophylline decreased PDGF-BB-induced expressions of cyclin D1 and CDK6, and inhibited p27^kip1 degradation. Furthermore, isorhynchophylline negatively regulated PDGF-BB-induced phosphorylation of PDGF-Rβ and its downstream signaling molecules, including AKT and glycogen synthase kinase (GSK) 3β. Conclusion Isorhynchophyl-line inhibited PDGF-BB-induced PASMCs proliferation via inducing G₀/G₁ phase arrest, the possible mechanism of which is that isorhynchophylline modulate synthesization and degradation of cell cycle-related protein by inhibiting PDGF-Rβ and its downstream signaling pathway.

Key words: Isorhynchophylline, Pulmonary artery smooth muscle cell, Proliferation, Glycogen synthase kinase 3β, Platelet-derived growth factor

中图分类号:

R543.2

张欣, 郭海鹏, 王振红, 唐琳娜, 杨洁, 吴大玮. 异钩藤碱抑制PDGF-BB诱导肺动脉平滑肌细胞增殖的实验研究[J]. 山东大学学报（医学版）, 2014, 52(12): 35-40.

ZHANG Xin, GUO Haipeng, WANG Zhenhong, TANG Linna, YANG Jie, WU Dawei. Effect and mechanism of isorhynchophylline on platelet-derived growth factor(PDGF)-BB-induced pulmonary artery smooth muscle cell proliferation[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 35-40.

参考文献

[1] Seeger W, Adir Y, Barbera J A, et al. Pulmonary hypertension in chronic lung diseases[J]. J Am Coll Cardiol, 2013, 62(25): 109-116.
[2] Rabinovitch M. Pathobiology of pulmonary hypertension[J]. Annu Rev Pathol, 2007, 2(1): 369-399.
[3] Balasubramaniam V, Le Cras T D, Lvy D D, et al. Role of plateletderived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus[J]. Am J Physiol Lung Cell Mol Physiol, 2003, 284(5): 826-833.
[4] Daemen M J, Lombardi D M, Bosman F T, et al. Angiotensin Ⅱ induces smooth muscle cell proliferation in the normal and injured rat arterial wall[J]. Circ Res, 1991, 68: 450-456.
[5] Xin X, Johnson A D, Scott-Burden T, et al. The predominant form of fibroblast growth factor receptor expressed by proliferating human arterial smooth muscle cells in culture is type I[J]. Biochem Biophys Res Commun, 1994, 204(2): 557-564.
[6] Jones P L, Cowan K N, Rabinovitch M. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease[J]. Am J Pathol, 1997, 150(4): 1349-1360.
[7] Perros F, Montani D, Dorfmüller P, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2008, 178(1): 81-88.
[8] Arcot S S, Lipke D W, Gillespie M N, et al. Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension[J]. Biochem Pharmacol, 1993, 46(6): 1086-1091.
[9] Nisbet R E, Bland J M, Kleinhenz D J, et al. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model[J]. Am J Respir Cell Mol Biol, 2010, 42(4): 482-490.
[10] Schermuly R T, Dony E, Ghofrani H A, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition[J]. J Clin Invest, 2005, 115(10): 2811-2821.
[11] Ndagijimana A, Wang X M, Pan G X, et al. A review on indole alkaloids isolated from Uncaria rhynchophylla and their pharmacological studies[J]. Fitoterapia, 2013, 86(10): 35-47.
[12] Li P Y, Zeng X R, Cheng J, et al. Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cells[J]. Naunyn-Schmiedeberg's Arch Pharmacol, 2013, 386(11): 973-982.
[13] Song Y, Qu R, Zhu S, et al. Rhynchophylline attenuates LPS-induced pro-inflammatory responses through downregulation of MAPK/NF-kB signaling pathways in primary microglia[J]. Phytother Res, 2012, 26(10): 1528-1533.
[14] Xian Y F, Lin Z X, Mao Q Q, et al. Protective effect of isorhynchophylline against β-amyloid-induced neurotoxicity in PC12 cells[J]. Cell Mol Neurobiol, 2012, 32(3): 353-360.
[15] 戴国华,孙敬昌,齐冬梅,等. 钩藤生物碱对自发性高血压大鼠胸主动脉成纤维细胞凋亡/增殖及FN、LN的影响[J]. 中国中西医结合杂志,2012,32(9):1233-1237. DAI Guohua, SUN Jingchang, QI Dongmei. Effects of rhynchophylla alkaloids on vascular adventitial fibroblast apoptosis and proliferation in the thoracic aorta of spontaneously hypertensive rats[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2012, 32(9):1233-1237.
[16] Zhang F, Sun A S, Yu L M, et al. Effects of isorhynchophylline on angiotensin II-induced proliferation in rat vascular smooth muscle cells[J]. J Pharm Pharmacol, 2008, 60(12): 1673-1678.
[17] Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer[J]. Nat Rev Cancer, 2001, 1(3): 222-231.
[18] Sherr C J, Roberts J M. CDK inhibitors: positive and negative regulators of G1-phase progression[J]. Genes Dev, 1999, 13(12): 1501-1512.
[19] Heldin C H, Ostman A, Rönnstrand L. Signal transduction via platelet-derived growth factor receptors[J]. Biochimica et Biophysica Acta, 1998,1378(1): F79-F113.
[20] Liang J, Slingerland J M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression[J]. Cell Cycle, 2003, 2(4): 339-345.
[21] Diehl J A, Cheng M, Roussel M F, et al. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization[J]. Genes Dev, 1998, 12(22): 3499-3511.
[22] Karpurapu M, Wang D, Van Quyen D, et al. Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling[J]. J Biol Chem, 2010, 285(5): 3510-3523.
[23] Tseng A S, Engel F B, Keating M T, et al. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes[J]. Chem Biol, 2006, 13(9): 957-963.

相关文章 15

[1]	王晓磊张海涛张辉郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[2]	殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73.
[3]	韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[4]	李观强,施昱诚,朱可涵,胡波,黄献琛,孙元,李笃信,张喜成. 蜗牛粘液来源的活性肽SK-14促进成纤维细胞的增殖和迁移[J]. 山东大学学报 (医学版), 2025, 63(11): 1-7.
[5]	张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42.
[6]	曹华琳,贾彦召,曲莉,尹昕. CircFAT1调节miR-296-3p/MAPRE1轴对鼻咽癌细胞增殖、凋亡和放疗敏感性的影响[J]. 山东大学学报 (医学版), 2023, 61(9): 38-46.
[7]	金珊,高杰,谢玉姣,展垚,杜甜甜,王传新. 甲基转移酶PRMT5稳定USP15促进乳腺癌发生发展的作用[J]. 山东大学学报 (医学版), 2023, 61(7): 1-11.
[8]	何静,严如根,武志红,李长忠. 消癥抑癌方对卵巢癌SKOV3细胞增殖、迁移的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 1-10.
[9]	董相君,李娟,孔雪,李培龙,赵文静,梁怡然,王丽丽,杜鲁涛,王传新. 环状RNA hsa_circ_0008591对乳腺癌细胞生物学行为的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 78-87.
[10]	赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[11]	张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84.
[12]	申晓畅,孙一卿,颜磊,赵兴波. 芳基烃受体核转位因子样蛋白2在子宫内膜癌中的表达[J]. 山东大学学报 (医学版), 2022, 60(5): 74-80.
[13]	宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26.
[14]	亓梦雨,周敏然,孙洺山,李世洁,陈春燕. T大颗粒淋巴细胞白血病合并原发性骨髓纤维化1例[J]. 山东大学学报 (医学版), 2022, 60(2): 118-120.
[15]	李卉,姜朝阳,刘岩,张曼. 组蛋白去乙酰化酶SIRT1调控氧化低密度脂蛋白诱导巨噬细胞凋亡的表达[J]. 山东大学学报 (医学版), 2022, 60(1): 6-12.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed